Paper

Antihyperglycaemic activity of ethylacetate extract of Chlorophytum alismifolium in type 2 diabetes: The involvement of peroxisome proliferator-activated receptor-γ and dipeptidyl peptidase-4.

Published Oct 29, 2020 · DOI · A. Abubakar, A. Nazifi, I. Maje

Journal of integrative medicine

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Non-RCTAnimal Study

Study Snapshot

The ethylacetate extract of Chlorophytum alismifolium tubers effectively reduces blood glucose levels in type 2 diabetes by increasing insulin secretion and PPAR- levels while decreasing DPP-4 activity.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Antihyperglycaemic activity of ethylacetate extract of Chlorophytum alismifolium in type 2 diabetes: The involvement of peroxisome proliferator-activated receptor-γ and dipeptidyl peptidase-4.

References

Citations